Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
This intro covers which coins are blue chip crypto and why they’re favored by investors. We outline criteria, track records, and what to watch before investing.
21,488 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
When T-Pain hits the Electric Forest stage with an unreleased Oliver Tree track, fans get a glimpse of more than a co...
A late-February U.S. intelligence assessment concluded that neither limited air strikes nor a prolonged war would lik...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
Grove Collaborative, trading as GROV, is navigating a challenging yet hopeful path. This article breaks down grove co...
The Premier League Lacrosse secures a $100 million funding round, bringing in entertainment and finance power to acce...
In March 2026, smart japan investors choosing hedged exposure via DXJ are gaining ground as currency moves and reform...
As AI data centers push energy use higher, nuclear power is being framed as the only real baseload option. This piece...
Market observers say political shocks, energy costs, and shifting policy paths are creating a fragile backdrop for ho...
Kratos Defense Security Solutions stock is on the move as defense spending and drone capabilities gain momentum. This...
Software stocks are rebounding as growth signals improve and enterprise demand remains resilient. Analysts warn that ...
A surprising gift disclosure involving a music label and a Supreme Court justice reveals the money-side of public tra...